<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://scemsprotocols.com/scems/index.php?action=history&amp;feed=atom&amp;title=Salicylates</id>
	<title>Salicylates - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://scemsprotocols.com/scems/index.php?action=history&amp;feed=atom&amp;title=Salicylates"/>
	<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Salicylates&amp;action=history"/>
	<updated>2026-04-05T12:32:34Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://scemsprotocols.com/scems/index.php?title=Salicylates&amp;diff=1024&amp;oldid=prev</id>
		<title>Treloars at 16:28, 1 February 2018</title>
		<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Salicylates&amp;diff=1024&amp;oldid=prev"/>
		<updated>2018-02-01T16:28:30Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 16:28, 1 February 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l14&quot;&gt;Line 14:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 14:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;DOSAGE&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;DOSAGE&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* 162 -324 mg chewed.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* 162 -324 mg chewed.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Medication Guidelines|0818]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Treloars</name></author>
	</entry>
	<entry>
		<id>https://scemsprotocols.com/scems/index.php?title=Salicylates&amp;diff=89&amp;oldid=prev</id>
		<title>Treloars: Created page with &quot;==Section 8 - MEDICATION GUIDELINES== ===8.18 SALICYLATES===  ====Aspirin (ASA) / Anti-inflammatory, platelet aggregation inhibitor====  &#039;&#039;&#039;DESCRIPTION&#039;&#039;&#039; * Commonly used over...&quot;</title>
		<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Salicylates&amp;diff=89&amp;oldid=prev"/>
		<updated>2012-02-02T21:35:06Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Section 8 - MEDICATION GUIDELINES== ===8.18 SALICYLATES===  ====Aspirin (ASA) / Anti-inflammatory, platelet aggregation inhibitor====  &amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039; * Commonly used over...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Section 8 - MEDICATION GUIDELINES==&lt;br /&gt;
===8.18 SALICYLATES===&lt;br /&gt;
&lt;br /&gt;
====Aspirin (ASA) / Anti-inflammatory, platelet aggregation inhibitor====&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Commonly used over the counter analgesic with thrombolytic properties.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;INDICATIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* [[Chest Pain Acute Coronary Syndrome|New chest pain suggestive of acute MI]].&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;CONTRAINDICATIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Patients with known hypersensitivity to the drug or active ulcer disease.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;PRECAUTIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* GI bleeding and upset. Possible side effects: Heartburn, nausea and vomiting.  Not recommended for Pediatric patients.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DOSAGE&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* 162 -324 mg chewed.&lt;/div&gt;</summary>
		<author><name>Treloars</name></author>
	</entry>
</feed>